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Objective: To explore the possible mechanisms behind the lower glycemic response observed when
extra-virgin olive oil (EVOO) is added to a high-glycemic index meal in patients with type 1 diabetes
(T1D).
Research design and methods: According to a randomized cross-over design, eleven T1D patients (6
women, 5 men) on insulin pump consumed in the metabolic ward, one week apart, three high-glycemic
index meals differing only for amount and quality of fat: high-monounsaturated fat (EVOO), high-
saturated fat (Butter), and low-fat (LF). Before and after the meals, blood glucose (continuous glucose
monitoring), gastric emptying rate (ultrasound technique), and plasma concentrations of glucagon-like
peptide 1 (GLP-1) and glucose-dependent insulinotropic polypeptide GIP (ELISA), glucagon (RIA), and
lipids (colorimetric assays) were evaluated.
Results: Blood glucose iAUC (mmol/lx360 min) was lower after the EVOO (690 ± 431) than after the
Butter (1320 ± 600) and LF meals (1007 ± 990) (M ± SD, p ¼ 0.041 by repeated measures ANOVA). Gastric
antrum volume was signiﬁcantly larger in the early (60e90 min) postprandial phase (106 ± 21 vs.
90 ± 16 ml, p ¼ 0.048) and signiﬁcantly smaller in the late phase (330e360 min) (46 ± 10 vs. 57 ± 22 ml,
p ¼ 0.045) after the EVOO than after Butter meal. EVOO signiﬁcantly increased postprandial GLP-1 iAUC
(261 ± 311) compared to Butter (189 ± 349) (pmol/Lx180 min, p ¼ 0.009). Postprandial GIP and glucagon
responses were not signiﬁcantly different between EVOO and Butter. Postprandial triglyceride iAUC was
signiﬁcantly higher after EVOO (100 ± 53) than after Butter (65 ± 60) (mmol/l  360 min, p ¼ 0.048).
Conclusions: Changes in gastric emptying and GLP-1 secretion and reduced glucose absorption through
glucose-lipid competition may contribute to lower glycemia after a high-glycemic index meal with EVOO
in T1D patients.
Clinical trials number: NCT02330939.
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Adding extra-virgin olive oil (EVOO) to a high glycemic index
meal attenuates the postprandial glucose response observed when
the meal is consumed with butter or very small amounts of fat, as
previously shown in a controlled study in real life conditions, in
patients with type 1 diabetes on insulin pump [1]. How EVOO in-
ﬂuences postprandial glycemia is unknown. The main pathophys-
iological regulators of postprandial glucose response may beism. All rights reserved.
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intestinal hormones [2].
Gastric emptying (GE) is a major determinant of postprandial
glycemia and is ﬁnely regulated by the characteristics of the meal.
In particular, the amount of fat in a meal is able to slow down
gastric emptying rate in healthy individuals [3] and in people with
type 1 diabetes [4]. As to the quality of fat, monounsaturated fatty
acids (MUFA) have been shown to slow down GE more than n-3
polyunsaturated (PUFA), n-6 PUFA, and saturated fatty acids (SFA)
in healthy people [5].
The quality of meal fat could inﬂuence gastric emptying through
changes in postprandial secretion of glucagon-like peptide 1 (GLP-
1) and glucose-dependent insulinotropic polypeptide (GIP). In
particular, MUFA seem to enhance GLP-1 secretion more than SFA
in both healthy people [6] and in patients with type 2 diabetes
[7e9], while GIP secretion seems to be increased by SFA and
reduced by ﬁsh oil compared to other types of fat in healthy people
[10,11]. GLP-1 could inﬂuence postprandial glucose response in
people with type 1 diabetes also independently of its effects on
gastric emptying, by exerting its glucagonostatic effects [12].
Another mechanism through which different types of fat could
inﬂuence postprandial glycemia is by eliciting a different post-
prandial lipemic response, since postprandial lipid and glucose
metabolism are reciprocally inﬂuenced and regulated [13].
Therefore, the aim of the present study was to explore the
possible mechanisms for the reduced postprandial glucose
response to a high glycemic index meal enriched with EVOO
observed in our previous home-based study. For this purpose, we
performed a new controlled study in the metabolic ward of our
Unit, involving patients with type 1 diabetes on insulin pump, to
evaluate the effects of different dietary fats on postprandial blood
glucose, gastric emptying and plasma levels of gastrointestinal
hormones and lipids.
2. Material and methods
Fourteen patients with type 1 diabetes (8 women and 6 men)
were recruited at the outpatient diabetes clinic of the Federico II
University Teaching Hospital (Naples, Italy). They were enrolled in
the study after giving their written informed consent. Inclusion
criteria were treatment with continuous subcutaneous insulin
infusion for at least 6 months and an HbA1c less than 8.0%
(64 mmol/mol). Exclusion criteria were pregnancy, celiac disease,
severe microvascular and macrovascular diabetes complications
including autonomic neuropathy possibly inﬂuencing gastric
emptying, and any other chronic or acute disease seriously affecting
health status.
Patients meeting the inclusion criteria were asked to participate
in the study at their regular outpatient follow-up visits. One subject
was excluded from the ﬁnal analysis because of a hypoglycemic
event during a test meal, and two subjects because of poor
compliance to the study design. Therefore, the analyses were per-
formed on 11 participants. The study protocol was approved by the
Federico II University Ethics Committee and registered at Clinical
Trials.gov, registration number: NCT02330939.
2.1. Study design
Before the intervention, patients underwent a one-week run-in
period on continuous glucose monitoring (CGM), andwere asked to
complete a seven-day dietary record. The run-in aimed at opti-
mizing basal infusion rate and insulin prandial dose calculation by
insulin/glycemic load ratio, determined as previously described
[14]. After run-in, according to a triple crossover design, partici-
pants consumed one of three experimental meals, alternating, atone-week intervals, in a random sequence determined by card
drawing. The three meals had a similar carbohydrate content but
different amounts and type of fat: 1) high-monounsaturated fat
(EVOO), 37 g, 2) high-saturated fat (Butter), 43 g, and 3) low-fat
(LF), 8 g EVOO.
The participants came to themetabolic ward in the late morning
and consumed the test meals at lunchtime under the supervision of
an expert dietitian. The test meals had been previously prepared in
a metabolic kitchen and kept frozen until the test day, when they
were defrosted and reheated on the cooker. The patients consumed
the meals and drank 250 ml of water within 15 min.
In case of pre-meal blood glucose levels outside the 5e8 mmol/l
range or a rapid decrease/increase of glucose levels (<3.0 mmol/l)
during the previous 60 min according to CGM measurement, the
test meal was postponed to the next week. On the three experi-
mental days, the participants were asked to consume at home, no
later than 7.00, the same light breakfast. They were asked to avoid
strenuous physical activity on the day before and on the morning of
the test meal, and to refrain from snacking or making insulin bo-
luses or changes in insulin basal rate over the 6 h prior to the test
meals. In female participants, the experiments were not performed
during menses. After meals, the subjects were asked to remain in
the upright position or sitting over 6 h, either reading, chatting, or
watching TV. Pre-meal insulin doses, injected just before eating,
were based on individual insulin/glycemic load ratio determined
during the patients’ educational sessions with the study team [14].
For each subject, the same insulin dose was administered before
each of the three experimental meals. No changes from habitual
insulin basal rateweremade during the 6-h postprandial phase and
between the three different test meals.
Over the whole experimental period, participants underwent
CGM. Moreover, on the test days, before and over the 6 h following
the meals, participants underwent gastric ultrasound for the eval-
uation of gastric emptying rate and venous blood sampling for the
measurement of GLP-1, GIP, glucagon, and concentrations of plasma
lipids.2.2. Test meals composition
The meals consisted of white rice (60 g), white bread (75 g),
minced beef (90 g), and banana (180 g) prepared with EVOO (37 g)
in the EVOO meal, butter (43 g) in the Butter meal, and EVOO (8 g)
in the Low-fat meal. The whole content of Butter and EVOO was
added to the meals before freezing. Energy content and total
amount of fat were similar for the EVOO (988 kcal; 40.5 g) and
Butter meals (982 kcal; 39.4 g); conversely, the Low-fat meal had a
lower energy content (721 kcal), due exclusively to the lower
content of fat (10.6 g). While macronutrient composition was
similar for amount of carbohydrate (130 g) and protein (34 g) in all
test meals, there was a substantial difference for saturated and
monounsaturated fat between the EVOO (6.5 g and 27.9 g), Butter
(22.1 g and 11.1 g), and Low-fat (2.2 g and 6.6 g) meals, respectively.
The small amount of fat in the Low-fat meal was necessary to allow
the preparation of a meal with a similar food composition as the
two fat-rich meals.2.3. Continuous glucose monitoring
Glucose monitoring was performed using the Enlite™ Sensor
Medtronic (n ¼ 7 participants) or the Dexcom G4® (n ¼ 4 partici-
pants) systems. At the end of the experimental period, data from
CGM and insulin pump were downloaded by dedicated informatics
platforms. Participants used the CGM system integrated with their
insulin pump, as it was the one they were accustomed to.
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Gastric emptying rate was evaluated using a MINDRAY M7
digital echographer with a convex-array scan (range 2e6 MHz).
Ultrasonographic scanning was done at the ﬁnal portion of the
stomach (antrum and pylorus) where constant viewing makes
volume measurement simpler. Scanning was performed with the
subjects standing up to favor air ﬂow towards the fundus of the
stomach. In order to calculate antral volume, three sagittal scans
were performed to measure anteroposterior (a, c and e, respec-
tively) and longitudinal (b, d and f, respectively) diameters. The ﬁrst
scan was taken on the angulus (transitional region between the
body of the stomach and the pylorus); the second, at an interme-
diate level corresponding to the superior mesenteric vein, which is
easily detectable; the third, at the level of the pyloric sphincter
where the thickness of the muscle wall is visible. Finally, the antral
length from the angulus to the pylorus (h) was measured with a
transversal scan. The volume of the antrum was calculated
using the formula by Bolondi et al. [15]:
0.065  h  (2ab þ 2efþ4cd þ cb þ ad þ ed þ cf). This method has
been previously validated against the scintigraphic method [16]. A
limitation of the ultrasound technique is that it is unable to
differentiate the relative emptying of solid, aqueous, and oil
components.
2.5. Laboratory assessment
2.5.1. Plasma gastrointestinal hormones
Blood samples were drawn before and 15, 30, 60, 90, 120, and
180 min after meal for the evaluation of GLP-1, GIP, and plasma
levels of glucagon. Blood in EDTA- or EDTA and aprotinin (for the
GLP-1 assay) tubes was centrifuged and plasma stored at 80 C
until measurement. Active GLP-1 was assayed by a nonradioactive,
highly speciﬁc sandwich ELISA (Merck- Millipore, Darmstadt, Ger-
many), which has a 100% cross-reactivity with the active isoforms
of GLP-1 (7e36 amide and 7e37 glycine extended) but no reactivity
with inactive isoforms (9e36 amide and 9e37 glycine extended),
GLP-2 or glucagon [17]. Total GIP was assayed by a nonradioactive,
highly speciﬁc sandwich ELISA (Merck-Millipore, Darmstadt, Ger-
many) with 100% cross reactivity with human GIP (1e42) and GIP
(3e42). The intra- and interassay coefﬁcients of variation of the
GLP-1 and GIP assays were <5% and <10%, respectively. Plasma
glucagon was assayed by competitive RIA using a rabbit antiserum
against a glucagonealbumin conjugate (Euria-Glucagon, Euro-
Diagnostica, Malm€o, Sweden). Glucagon in standards and samples
compete with 125I labeled glucagon in binding to the antibodies in
a two-step incubation. Antibody-bound 125I-glucagon is separated
from the unbound fraction using double antibody solid phase and
measured in a gamma counter. The limit of sensitivity for the
glucagon assays was 3 pmol/l. The intra- and interassay coefﬁcients
of variation were <10%.
2.5.2. Other measurements
Plasma triglyceride (Roche Molecular Biochemicals, Mannheim,
Germany) and FFA (Wako Chemicals GmbH, Neuss, Germany) were
measured before and 60,120,180, 240, 300 and 360min aftermeals
by a Roche Cobas Mira autoanalyzer (ABX Diagnostics, Montpellier,
France) using a colorimetric assay. All laboratory analyses were
performed blinded to the assigned treatment.
2.6. Statistical analysis
A sample size of 13 participants with a randomized crossover
design was determined. In our previous study, this size had been
sufﬁcient to discriminate the postprandial blood glucose patternsbetween EVOO and butter [1]. Being a mechanistic study, multiple
endpoints were selected, namely postprandial changes in gastric
emptying rate, gastrointestinal hormones, and blood lipids.
Data are expressed as mean ± standard deviation (SD) unless
otherwise stated. Differences in postprandial glucose, hormones,
and lipid proﬁles were evaluated by two-way repeated-measures
ANOVA. Postprandial concentrations were included as levels of the
within-subject factor time, and EVOO, Butter, and Low-fat were
included as levels of the within-subject factor test-meal. Post-
prandial incremental area (iAUC) was calculated by the trapezoidal
rule as the area under the curve above the baseline value. Differ-
ences between the three experimental meals in iAUCs or single
time-point values were evaluated by one-way repeated measures
ANOVA or, when datawere not normally distributed, by Friedman's
analysis of variance by ranks. A p-value <0.05 was considered
signiﬁcant. Statistical analysis was performed according to stan-
dard methods using the Statistical Package for Social Sciences
software 21.0 (SPSS/PC; SPSS, Chicago, IL, USA).
3. Results
3.1. Participants’ characteristics
The study participants (5 men and 6 women) were 41 ± 9
(mean ± SD) years old and had a BMI of 24.9 ± 2.2 kg/m2. Diabetes
duration was 25 ± 9 years, and blood glucose control was accept-
able (HbA1c 7.0 ± 0.6%; 53 ± 6 mmol/mol). Their total daily insulin
dose was 41.9 ± 10.9 IU. As determined based on the individual
insulin/glycemic load ratios, insulin doses administered before the
three experimental meals were the same for each subject, ranging
between 5 and 16 IU. One participant had background retinopathy
and two had both background retinopathy and peripheral
neuropathy.
Gastric volume and plasma concentrations of glucose, gastro-
intestinal hormones, and lipids did not differ before the EVOO,
Butter, and Low-fat meals. Data are reported in Supplemental
Table S1.
3.2. Postprandial glycemia
Postprandial blood glucose response to the EVOO meal was
blunted compared with the Butter and Low-fat meals (p < 0.037 for
time  meal interaction by two-way repeated measures ANOVA)
(Fig. 1). Blood glucose progressively increased in the later time of
observation (3e6 h) after the two fat meals, at variance with the
Low-fat meal, which peaked at 2 h. Differences between the EVOO
and Butter meals were also evident in the later postprandial phase.
Blood glucose iAUC was signiﬁcantly lower after the meal with
EVOO (690 ± 431) than with Butter (1320 ± 600) or Low-fat
(1007 ± 990) (mmol/l  360 min; p ¼ 0.041, repeated measures
ANOVA; EVOO vs. Butter, p ¼ 0.004).
3.3. Gastric emptying
Gastric antrum volume in the early postprandial phase was
signiﬁcantly larger after the EVOO than after the Butter meal (mean
values 60e90 min: 106 ± 21 vs. 90 ± 16 ml, p ¼ 0.048), indicating a
slower gastric emptying after EVOO (Fig. 2). Conversely, at the end
of the observation, antrum volume was signiﬁcantly smaller after
the EVOO than after the Butter meal (mean values 330e360 min:
46 ± 10 vs. 57 ± 22 ml, p ¼ 0.045).
Combining all meals, in the late postprandial phase, blood
glucose levels (mean values 300e330 min) were signiﬁcantly and
positively correlated with gastric antrum volumes at 330 min
(r ¼ 0.528, p ¼ 0.002) and 360 min (r ¼ 0.493, p ¼ 0.004).
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Fig. 1. Absolute changes vs. baseline (t0) in blood glucose concentrations after EVOO (full squares), Butter (empty circles), and Low-fat (empty squares) meals (p ¼ 0.037 for
time  meal interaction by two-way repeated measures ANOVA; EVOO vs. Butter, p ¼ 0.004).
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Fig. 2. A. Absolute changes vs. baseline (t0) in gastric antrum volume after EVOO (full squares), Butter (empty circles), and Low-fat (empty squares) meals. Data in the ﬁgure are
means and SEM. *p < 0.05 EVOO vs. Butter.
L. Bozzetto et al. / Clinical Nutrition 38 (2019) 2645e265126483.4. Postprandial hormones
GLP-1 plasma concentrations at 15, 30, and 60 min increased
signiﬁcantlymore after the EVOO than after the Butter and LFmeals
(Fig. 3A). Postprandial GLP-1 iAUC was signiﬁcantly higher after the
EVOO (261 ± 311) than after the Butter (189 ± 349) and LF meals
(180 ± 337) (pmol/l  180 min; p ¼ 0.009 by repeated measures
ANOVA; p¼ 0.028 EVOO vs. Butter, p¼ 0.004 EVOO vs. LF) (Fig. 3B).
There was a two-fold increase in plasma GIP concentrations
after the EVOO and Butter meals than after LF meal, with signiﬁcant
differences between the two fat-rich meals and the low fat meal at
all postprandial time-points (Fig. 3C). Postprandial GIP iAUC was
signiﬁcantly higher after the EVOO (18873 ± 7250) and Butter
(17217 ± 5344) than after LF meals (10634 ± 3680) (pmol/
l  180 min; p < 0.001 by repeated measures ANOVA; p ¼ 0.001
EVOO vs. LF, p ¼ 0.001 Butter vs. LF) (Fig. 3D).
Plasma glucagon concentrations increased only slightly after the
three meals (on average less than 10%) with a polyphasic pattern
and without an evident peak. The high variability due to the smallpostprandial changes could explain some differences between the
statistical tests. The postprandial concentration of glucagon
increased signiﬁcantly after EVOO at 15, 60, and 120 min when
compared to LF, and at 15 and 120 min when compared to the
butter meal. The mean concentration at all time-points
(15e180 min) was signiﬁcantly higher after both the EVOO and
Butter (46.3± 8.0 and 47.0 ± 8.7, respectively) than after the LFmeal
(42.5 ± 8.0) (pmol/l, p ¼ 0.013 by repeated measures ANOVA)
(Fig. 3E). However, glucagon postprandial iAUCs were not signiﬁ-
cantly different between the three meals (p ¼ 0.503) (Fig. 3F).
3.5. Postprandial lipids
Plasma triglyceride concentrations increased signiﬁcantly more
after the two fat-rich meals than after the low-fat meal, with a
signiﬁcantly higher increase after EVOO than after Butter at 60, 120,
and 360 min (p ¼ 0.005 for time  meal interaction by two-way
repeated measures ANOVA) (Fig. 4A). Postprandial triglyceride
iAUC was signiﬁcantly higher after EVOO (100 ± 53) than after the
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Fig. 3. Absolute changes vs. baseline (t0) in plasma concentrations of GLP-1 (A), GIP (C), and glucagon (E) after EVOO (full squares), Butter (empty circles), and Low-fat (empty
squares) meals. GLP-1 (B), GIP (D), and glucagon (F) postprandial iAUCs after the three test meals. Data in the ﬁgure are means and SEM. *p < 0.05 vs. Butter; yp < 0.05 vs. Low-fat.
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p < 0.001 by repeatedmeasures ANOVA; p¼ 0.048 EVOO vs. Butter,
p < 0.001 EVOO vs. LF, p < 0.014 Butter vs. LF) (Fig. 4B).
Postprandial FFA concentrations were less suppressed after the
EVOO meal than after the Butter and LF meals, with signiﬁcant
differences at 60 and 120 min (Fig. 4C). The difference in post-
prandial FFA iAUCs after the EVOO and Butter meals tended to be
statistically signiﬁcant (80 ± 91 vs.203 ± 174 mEq/L  360 min,
respectively; p ¼ 0.066) (Fig. 4D).
4. Discussion
The present study conﬁrms, in a controlled setup, our previous
home-based ﬁndings that the addition of EVOO to a high-glycemic
index meal reduces postprandial glycemia, and shows thatdifferential changes in gastric emptying, increased GLP-1 secre-
tion, a more pronounced postprandial triglyceride response and
lower postprandial free fatty acids inhibition may contribute to
this effect.
In our study, EVOO slowed down early gastric emptying, as
shown by signiﬁcant differences in early postprandial gastric vol-
umes between EVOO and butter intake. This suggests that only
early postprandial changes in gastric emptying contributed to
reducing postprandial glycemia. During the late postprandial
phase, in line with a bidirectional relationship between gastric
emptying and hyperglycemia [18], a more relevant factor slowing
down gastric emptying may became the higher blood glucose
levels. This is also suggested, in our study, by the signiﬁcant and
positive correlations between blood glucose concentrations and
gastric volumes observed 6 h after the meals.
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higher postprandial increase in plasma GLP-1 concentrations than
did the butter or low fat meals. Although GLP-1 is mainly a glucose-
dependent insulin secretagogue, its postprandial secretion is pre-
served in people with type 1 diabetes [12,19], and the extent of
postprandial GLP-1 response is inﬂuenced by meal size and fat
content meal [4,9,19,20]. There is also evidence that the quality of fat
may inﬂuence postprandial GLP-1 secretion. In particular, mono-
unsaturated fatty acids given either as fat emulsion in healthy people
[21] or as olive oil in healthy people [6] and in patients with type 2
diabetes [7] increased postprandial GLP-1 secretion compared to
butter. Conversely, EVOO increased postprandial GLP-1 secretion to
the same extent as butter compared with carbohydrate alone in in-
sulin resistant individuals [22]. Our study shows that the quality of
fat added to a high glycemic index meal modulates the postprandial
increase in GLP-1 concentrations also in people with type 1 diabetes,
possibly contributing to the lower postprandial blood glucose
response observed after EVOO consumption. Considering that GLP-1
increased in the very early postprandial phase, we can speculate that
this was due to indirect stimulation, likely through a neuro/endo-
crine pathway. While in healthy people and in patients with type 2
diabetes blood glucose lowering by endogenous or exogenous GLP-1
is mainly related to the stimulation of insulin secretion, this mech-
anism of action unlikely played a role in our patients with type 1
diabetes of long duration. The concomitant increases in plasma GLP-
1 and gastric volume during the early postprandial phase in our
study support the possibility that EVOO may have reduced post-
prandial glycemia by slowing down gastric emptying through the
stimulation of GLP-1 secretion [23].As another potential mechanism, we investigated the glucago-
nostatic effect of GLP-1 shown with exogenous GLP-1 in patients
with type 1 diabetes [24]. In our study, in line with Kielgast et al.
[12], we observed a slight postprandial increase in glucagon levels,
which tended to be even higher after EVOO. Consequently, it is
unlikely that the higher GLP-1 concentrations due to EVOO acted
through glucagon suppression. Possibly, the postprandial glucagon
increase in our patients was, instead, a consequence of the post-
prandial GIP increase, which was signiﬁcantly higher after both
high-fat meals than after the low-fat meal, as previously observed
by Lund et al. [25] in patients with type 2 diabetes.
EVOO may have exerted its postprandial hypoglycemic effects
also by inﬂuencing carbohydrate absorption at the intestinal level.
The consistent increases in GIP, GLP-1, and glucagon in response to
the fat-meals suggests that dietary fats stimulate the regulation of
postprandial hormonal response more than carbohydrates. In the
intestine, the absorption of fat competes with the absorption of
carbohydrates, thus blunting the latter [13]. This may hold partic-
ularly true for monounsaturated fatty acids, which are preferen-
tially absorbed compared with other types of fat [26]. Consistent
with this, we observed a higher triglyceride response and a lower
FFA suppression after EVOO meals. A higher postprandial increase
in plasma triglyceride and free fatty acids with EVOO than with
butter has been observed in studies on healthy people [27]. Like-
wise, in patients with type 2 diabetes, despite its beneﬁcial chronic
effects on fasting parameters, EVOO determined a higher post-
prandial triglyceride response mainly related to an increase in li-
poproteins of intestinal origin and, therefore, to a direct effect of
dietary fatty acids [28,29].
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The present study explored for the ﬁrst time the possible
mechanisms underlying the reduced postprandial glycemic
response determined by the addition of EVOO to a high glycemic
index meal. These results indicate that EVOO improves post-
prandial glucose response in patients with type 1 diabetes through
complex interactions between the macronutrient composition of
the meal and gastro-intestinal sensing that involve gastric
emptying, incretins secretion, and lipid metabolism. Moreover, this
study conﬁrms, in well-controlled experimental conditions, the
differences in postprandial blood glucose proﬁles observed in our
previous home-based study. This has relevant direct implications in
the treatment of patients with type 1 diabetes, as it shows that
insulin doses and time/duration of administration may differ
consistently after meals with a similar amount of carbohydrates
and total fat. This information may be especially useful for patients
on insulin pump and can be of help in deﬁning algorithms for the
determination of prandial insulin administration.
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